Dunn GP - Search Results

1

Murine cytomegalovirus paralyzes macrophages by blocking IFN gamma-induced promoter assembly.

Popkin DL, Watson MA, Karaskov E, Dunn GP, Bremner R, Virgin HW 4th. Popkin DL, et al. Among authors: dunn gp. Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14309-14. doi: 10.1073/pnas.1835673100. Epub 2003 Nov 12. Proc Natl Acad Sci U S A. 2003. PMID: 14614150 Free PMC article.

2

Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection.

Sheehan KC, Lai KS, Dunn GP, Bruce AT, Diamond MS, Heutel JD, Dungo-Arthur C, Carrero JA, White JM, Hertzog PJ, Schreiber RD. Sheehan KC, et al. Among authors: dunn gp. J Interferon Cytokine Res. 2006 Nov;26(11):804-19. doi: 10.1089/jir.2006.26.804. J Interferon Cytokine Res. 2006. PMID: 17115899

3

IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression.

Dunn GP, Sheehan KC, Old LJ, Schreiber RD. Dunn GP, et al. Cancer Res. 2005 Apr 15;65(8):3447-53. doi: 10.1158/0008-5472.CAN-04-4316. Cancer Res. 2005. PMID: 15833880

4

A critical function for type I interferons in cancer immunoediting.

Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, Diamond MS, Koebel CM, Arthur C, White JM, Schreiber RD. Dunn GP, et al. Nat Immunol. 2005 Jul;6(7):722-9. doi: 10.1038/ni1213. Epub 2005 Jun 12. Nat Immunol. 2005. PMID: 15951814

5

Interferon-gamma and cancer immunoediting.

Dunn GP, Ikeda H, Bruce AT, Koebel C, Uppaluri R, Bui J, Chan R, Diamond M, White JM, Sheehan KC, Schreiber RD. Dunn GP, et al. Immunol Res. 2005;32(1-3):231-45. doi: 10.1385/ir:32:1-3:231. Immunol Res. 2005. PMID: 16106075 Review.

6

Type I interferon is selectively required by dendritic cells for immune rejection of tumors.

Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault JM, Lee H, Arthur CD, White JM, Kalinke U, Murphy KM, Schreiber RD. Diamond MS, et al. Among authors: dunn gp. J Exp Med. 2011 Sep 26;208(10):1989-2003. doi: 10.1084/jem.20101158. Epub 2011 Sep 19. J Exp Med. 2011. PMID: 21930769 Free PMC article.

7

The immunobiology of cancer immunosurveillance and immunoediting.

Dunn GP, Old LJ, Schreiber RD. Dunn GP, et al. Immunity. 2004 Aug;21(2):137-48. doi: 10.1016/j.immuni.2004.07.017. Immunity. 2004. PMID: 15308095 Free article. Review.

8

T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma.

Woroniecka K, Chongsathidkiet P, Rhodin K, Kemeny H, Dechant C, Farber SH, Elsamadicy AA, Cui X, Koyama S, Jackson C, Hansen LJ, Johanns TM, Sanchez-Perez L, Chandramohan V, Yu YA, Bigner DD, Giles A, Healy P, Dranoff G, Weinhold KJ, Dunn GP, Fecci PE. Woroniecka K, et al. Among authors: dunn gp. Clin Cancer Res. 2018 Sep 1;24(17):4175-4186. doi: 10.1158/1078-0432.CCR-17-1846. Epub 2018 Feb 7. Clin Cancer Res. 2018. PMID: 29437767 Free PMC article.

9

Cancer immunoediting: from immunosurveillance to tumor escape.

Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Dunn GP, et al. Nat Immunol. 2002 Nov;3(11):991-8. doi: 10.1038/ni1102-991. Nat Immunol. 2002. PMID: 12407406 Review.

10

The three Es of cancer immunoediting.

Dunn GP, Old LJ, Schreiber RD. Dunn GP, et al. Annu Rev Immunol. 2004;22:329-60. doi: 10.1146/annurev.immunol.22.012703.104803. Annu Rev Immunol. 2004. PMID: 15032581 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page